Ratings
0
Nobody has rated this yet. Be the first!
Works
12
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease
Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study
Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/
Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints
